Literature DB >> 2141380

Plasma beta-endorphin concentration: response to intensity and duration of exercise.

A H Goldfarb1, B D Hatfield, D Armstrong, J Potts.   

Abstract

Twelve college-age men exercised on a bicycle ergometer to VO2max and at 60, 70, and 80% VO2max for 30 min to determine the effects of exercise intensity on plasma beta-endorphin (B-EP). The time course for alterations in B-EP and the relationship to lactate were also examined. Following the VO2max test, the three submaximal intensities were completed on separate days using a counter-balanced design. Blood was sampled from an indwelling venous catheter at rest during exercise and recovery to assess the time course response. B-EP content was determined by radioimmunoassay (Immunonuclear) with less than 5% cross-reactivity to B-LPH. At rest, B-EP content was similar across visits, 4.34 +/- 0.36 pmol.l-1. The 60% intensity did not elevate B-EP at any time measured. B-EP content increased by 15 min at 70% VO2max with a further increase at 30 min. B-EP remained elevated during the 20 min recovery. At 80% VO2max B-EP content increased by 5 min. B-EP continued to increase during the exercise and peaked at 21.91 +/- 2.03 pmol.l-1 5 min into the recovery. Lactate showed a mild correlation with B-EP (r = 0.43) at 80% VO2max. A significant correlation (r = 0.78) between lactate and B-EP did occur with the VO2max test. It is concluded that an exercise intensity of at least 70% VO2max for 15 min is needed to increase plasma B-EP. Furthermore, the higher the exercise intensity the more rapid the onset for increases in plasma B-EP.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2141380

Source DB:  PubMed          Journal:  Med Sci Sports Exerc        ISSN: 0195-9131            Impact factor:   5.411


  28 in total

Review 1.  The exercise-induced growth hormone response in athletes.

Authors:  Richard J Godfrey; Zahra Madgwick; Gregory P Whyte
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

Review 2.  Beta-endorphin response to exercise. An update.

Authors:  A H Goldfarb; A Z Jamurtas
Journal:  Sports Med       Date:  1997-07       Impact factor: 11.136

3.  Met-enkephalin, beta-endorphin and cortisol responses to sub-maximal exercise after sleep disturbances.

Authors:  F Mougin; M L Simon-Rigaud; C Mougin; H Bourdin; M C Jacquier; M T Henriet; D Davenne; J P Kantelip; P Magnin; R C Gaillard
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1992

4.  The use of heart rate to monitor the intensity of endurance training.

Authors:  M B Gilman
Journal:  Sports Med       Date:  1996-02       Impact factor: 11.136

5.  Pituitary-adrenal responses to arm versus leg exercise in untrained man.

Authors:  Carl M Maresh; Bülent Sökmen; William J Kraemer; Jay R Hoffman; Greig Watson; Daniel A Judelson; Catherine L Gabaree-Boulant; Michael R Deschenes; Jaci L Vanheest; Lawrence E Armstrong
Journal:  Eur J Appl Physiol       Date:  2006-05-10       Impact factor: 3.078

6.  Influence of fitness on the integrated neuroendocrine response to aerobic exercise until exhaustion.

Authors:  A M de Diego Acosta; J C García; V J Fernández-Pastor; S Perán; M Ruiz; F Guirado
Journal:  J Physiol Biochem       Date:  2001-12       Impact factor: 4.158

Review 7.  Hormonal responses and adaptations to resistance exercise and training.

Authors:  William J Kraemer; Nicholas A Ratamess
Journal:  Sports Med       Date:  2005       Impact factor: 11.136

8.  Intensity thresholds for aerobic exercise-induced hypoalgesia.

Authors:  Kelly Marie Naugle; Keith E Naugle; Roger B Fillingim; Brian Samuels; Joseph L Riley
Journal:  Med Sci Sports Exerc       Date:  2014-04       Impact factor: 5.411

Review 9.  Does exercise make migraines worse and tension type headaches better?

Authors:  Nada Ahmad Hindiyeh; John Claude Krusz; Robert Paul Cowan
Journal:  Curr Pain Headache Rep       Date:  2013-12

Review 10.  Blood hormones as markers of training stress and overtraining.

Authors:  A Urhausen; H Gabriel; W Kindermann
Journal:  Sports Med       Date:  1995-10       Impact factor: 11.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.